Jacques-André Haury, a physician and politician from Vaud, shares his views on rising health care costs and the importance of the responsibility of physicians and the media in containing expenses in the Swiss health care system. For decades, the Swiss health care system has faced constant...
Switzerland is committed to promoting the use of biosimilars as a cost-effective alternative to original biologic drugs. According to the Swiss Biosimilars Barometer 2023, underutilization of biosimilars resulted in lost savings of 90 million francs. To reverse this...
Insurance company Groupe Mutuel recently notified its policyholders of an important update regarding reimbursement for alternative medicine therapies. In a communication, the company informed that starting in March 2024, checks have been intensified at the...